Dolutegravir sodium

• Description:

  Dolutegravir sodium (GSK-1349572A) is a potent, next-generation HIV integrase (IN) inhibitor, inhibits HIV-1 integrase-catalyzed strand transfer with IC50 of 2.7 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  441.3606

• Molecular Formula:

  C20H18F2N3NaO5

• Notes:

  Research use only, not for human use.

• Receptor:

  HIVintegrase

• CAS Number:

  1051375-19-9